Bank of America Securities Reaffirms 'Buy' Rating for Mengniu Dairy with Unchanged HK$21 Target Price

Deep News
06/09

Bank of America Securities has issued a research report stating that the recent share price of Mengniu Dairy (02319) has been subjected to irrational selling, primarily driven by misinformation and misunderstanding, thus creating a particularly attractive buying opportunity. The bank's channel checks indicate that Mengniu's sales in May recorded positive growth, in contrast to widespread market rumors of a potential decline. Furthermore, April and May are typically off-peak seasons, with market focus on channel inventory, making it difficult to predict underlying trends. Bank of America Securities expects Mengniu's dividend yield to reach 4.5% in 2026. The firm reiterates its 'Buy' rating on Mengniu, maintaining an unchanged target price of HK$21.

Bank of America Securities notes that the company's operational performance year-to-date has also exceeded the median of its guidance for mid-to-high single-digit sales growth in fiscal 2026. This is coupled with a lower base in the second half of 2025 (with sales declining 7.6% in H2 2025 and 6.9% in H1 2025, respectively) and expected benefits from the earlier timing of the Lunar New Year in 2027. Following a reduction in raw milk production capacity of approximately 10% since 2024 (from 6.5 million heads to 5.84 million), China's contract milk price has stabilized at RMB 3 per kilogram since mid-2025. Concurrently, the non-contract milk prices of smaller peers have converged with contract price levels, with the discount rate narrowing from over 50% at its peak to less than 10% currently. This levels the competitive playing field, driving a recovery in Mengniu's market share. The bank anticipates that the capacity reduction process will resume, supporting an eventual supply-demand balance and leading to a moderate recovery in milk prices. It expects leading companies like Mengniu to enjoy lower procurement costs than their peers, enabling further market share recovery and improvement in average selling prices.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10